文献速递复苏、休克与脓毒症

院外心脏骤停患者肾上腺素给药途径对30天良好神经功能生存的影响(ETIVIO研究)

Impact of the route of adrenaline administration in patients suffering from out-of-hospital cardiac arrest on 30-day survival with good neurological outcome (ETIVIO study).
PubMed 文献 · Scand J Trauma Resusc Emerg Med · 2023-03-30
一句话结论德国复苏登记数据显示,院外心脏骤停CPR中经静脉给予肾上腺素者出院时CPC 1/2的比例优于经骨内或骨内联合静脉给药,经气管联合静脉与单纯静脉无显著差异。

该研究基于德国复苏登记(GRR)1989—2020年212,228例院外心脏骤停(OHCA)患者,纳入OHCA、给予肾上腺素且院外CPR者,排除<18岁、创伤或出血为可疑病因及数据不完整者,比较静脉(IV)、骨内(IO)、IO+IV、ET+IV四种肾上腺素给药途径对出院时良好神经功能(CPC 1/2)的影响,采用配对分析和二元logistic回归。配对比较中IV组(n=2416)出院CPC 1/2优于IO组(n=1208)(OR 2.43,95%CI 1.54–3.84,p<0.01);IV组(n=8706)优于IO+IV组(n=4353)(OR 1.33,95%CI 1.12–1.59,p<0.01);IV组(n=532)与ET+IV组(n=266)无显著差异(OR 1.26,95%CI 0.55–2.90,p=0.59)。logistic回归显示血管通路类型对出院CPC 1/2有显著影响(χ²=67.744(3),p<0.001),IO(回归系数-0.766,p=0.001)和IO+IV(回归系数-0.201,p=0.028)相对IV为负效应,ET+IV无显著效应(回归系数0.117,p=0.770)。作者认为该数据似乎强调院外CPR需给予肾上腺素时IV通路的重要性,IO给药可能效果较差,2010年从国际指南中删除的ET途径可能再次成为替代途径。

要点

  • 配对分析中IV组(n=2416)出院CPC 1/2优于IO组(n=1208),OR 2.43(95%CI 1.54–3.84,p<0.01)。
  • 配对分析中IV组(n=8706)出院CPC 1/2优于IO+IV组(n=4353),OR 1.33(95%CI 1.12–1.59,p<0.01)。
  • 配对分析中IV组(n=532)与ET+IV组(n=266)出院CPC 1/2无显著差异,OR 1.26(95%CI 0.55–2.90,p=0.59)。
  • logistic回归示血管通路类型对出院CPC 1/2有显著影响(χ²=67.744(3),p<0.001),IO(r.c.=-0.766,p=0.001)与IO+IV(r.c.=-0.201,p=0.028)相对IV为负效应,ET+IV无显著效应(r.c.=0.117,p=0.770)。
  • 作者认为该31年GRR数据似乎强调院外CPR需给肾上腺素时IV通路的重要性,IO给药可能效果较差,ET途径可能再次成为替代途径。

适用人群与场景

  • 德国复苏登记(GRR)1989—2020年院外心脏骤停(OHCA)患者,共212,228例。
  • 纳入标准:OHCA、给予肾上腺素、院外CPR。
  • 排除标准:年龄小于18岁、创伤或出血为可疑心脏骤停原因、数据集不完整。

研究设计与关键结果

  • 研究类型:基于德国复苏登记(GRR)的登记分析,1989—2020年共212,228例OHCA患者。
  • 比较四种肾上腺素给药途径:IV、IO、IO+IV、ET+IV;采用配对分析和二元logistic回归。
  • 主要临床终点为出院时良好神经功能(CPC 1/2);配对比较IV组(n=2416)优于IO组(n=1208),OR 2.43(95%CI 1.54–3.84,p<0.01)。
  • 配对比较IV组(n=8706)优于IO+IV组(n=4353),OR 1.33(95%CI 1.12–1.59,p<0.01)。
  • 配对比较IV组(n=532)与ET+IV组(n=266)无显著差异,OR 1.26(95%CI 0.55–2.90,p=0.59)。
  • 二元logistic回归示血管通路类型对出院CPC 1/2有显著影响(χ²=67.744(3),p<0.001);相对IV,IO为负效应(回归系数-0.766,p=0.001),IO+IV为负效应(回归系数-0.201,p=0.028),ET+IV无显著效应(回归系数0.117,p=0.770)。

证据类型、等级与局限

  • 证据类型:基于德国复苏登记(GRR)的登记分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,GRR数据似乎强调院外CPR需给予肾上腺素时IV通路的重要性。
  • 作者认为,IO给予肾上腺素可能效果较差。
  • 作者认为,2010年从国际指南中删除的ET途径可能再次成为替代途径。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Over the past decades, international guidelines for cardiopulmonary resuscitation (CPR) have changed the recommendation for alternative routes for drug administration. Until now, evidence for the substantial superiority of one route with respect to treatment outcome after CPR has been lacking. The present study compares the effects of intravenous (IV), intraosseous (IO) and endotracheal (ET) adrenaline application during CPR in out-of-hospital cardiac arrest (OHCA) on clinical outcomes within the database of the German Resuscitation Registry (GRR).

METHODS: This registry analysis was based on the GRR cohort of 212,228 OHCA patients between 1989 and 2020. Inclusion criteria were: OHCA, application of adrenaline, and out-of-hospital CPR. Excluded from the study were patients younger than 18 years, those who had trauma or bleeding as suspected causes of cardiac arrest, and incomplete data sets. The clinical endpoint was hospital discharge with good neurological outcome [cerebral performance category (CPC) 1/2]. Four routes of adrenaline administration were compared: IV, IO, IO + IV, ET + IV. Group comparisons were done using matched-pair analysis and binary logistic regression.

RESULTS: In matched-pair group comparisons of the primary clinical outcome hospital discharge with CPC 1/2, the IV group (n = 2416) showed better results compared to IO (n = 1208), [odds ratio (OR): 2.43, 95% confidence interval (CI): 1.54-3.84, p < 0.01] and when comparing IV (n = 8706) to IO + IV (n = 4353), [OR: 1.33, 95% CI: 1.12-1.59, p < 0.01]. In contrast, no significant difference was found between IV (n = 532) and ET + IV (n = 266), [OR: 1.26, 95% CI: 0.55-2.90, p = 0.59]. Concurrently, binary logistic regression yielded a highly significant effect of vascular access type (χ² = 67.744(3), p < 0.001) on hospital discharge with CPC1/2, with negative effects for IO (regression coefficient (r.c.) = - 0.766, p = 0.001) and IO + IV (r.c. = - 0.201, p = 0,028) and no significant effect for ET + IV (r.c. = 0.117, p = 0.770) compared to IV.

CONCLUSIONS: The GRR data, collected over a period of 31 years, seem to emphasize the relevance of an IV access during out-of-hospital CPR, in the event that adrenaline had to be administered. IO administration of adrenaline might be less effective. ET application, though removed in 2010 from international guidelines, could gain importance as an alternative route again.

来源:Scand J Trauma Resusc Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Monaco T, Fischer M, Michael M, et al. Impact of the route of adrenaline administration in patients suffering from out-of-hospital cardiac arrest on 30-day survival with good neurological outcome (ETIVIO study). Scand J Trauma Resusc Emerg Med. 2023. PMID: 36997973. doi:10.1186/s13049-023-01079-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。